Literature DB >> 6354540

Myoencephalopathies with abnormal mitochondria: a review.

G F Walter.   

Abstract

Myoencephalopathies with abnormal mitochondria comprise a heterogeneous group of diseases and syndromes with a large diversity of clinical signs. Thus, their identification and classification pose many difficulties. The underlying biochemical disorders of energy metabolism evoke non-specific structural alterations of the mitochondria in skeletal muscle and brain, but also in other organs. In this paper the morphologic and biochemical background of confirmed cases is reviewed and the position of these cases within the concept of mitochondriopathy is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354540

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  7 in total

1.  Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells.

Authors:  H R Scholte; H F Busch; I E Luyt-Houwen; M H Vaandrager-Verduin; H Przyrembel; W F Arts
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

2.  Myopathy with mitochondrial abnormalities and rimmed vacuoles.

Authors:  J Lehmann; J Ziegan; G Oertel; J Lössner; H J Kühn
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Congenital Leigh's disease: panencephalomyelopathy and peripheral neuropathy.

Authors:  R J Seitz; K Langes; H Frenzel; G Kluitmann; W Wechsler
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Neuropathology of myoclonus epilepsy associated with ragged-red fibers (Fukuhara's disease).

Authors:  S Takeda; K Wakabayashi; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 5.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

6.  Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

Authors:  S Levak-Frank; H Radner; A Walsh; R Stollberger; G Knipping; G Hoefler; W Sattler; P H Weinstock; J L Breslow; R Zechner
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

7.  Mitochondrial encephalomyopathy with pilovacuolar inclusion or phenocopy with mitochondrial artefact?

Authors:  W Paulus; A Stevens; W Roggendorf
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.